Page last updated: 2024-08-24

fluorodeoxyglucose f18 and arabinofuranosyluracil

fluorodeoxyglucose f18 has been researched along with arabinofuranosyluracil in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akhurst, T; Alauddin, MM; Balatoni, J; Blasberg, RG; Bornmann, W; Cai, S; Conti, PS; Doubrovin, M; Finn, R; Thaler, H; Tjuvajev, JG	1
Collins, JM; Mangner, TJ; Muzik, O; Shields, AF; Sun, H	1
Deng, WP; Gelovani, JG; Hwang, JJ; Lin, M; Liu, RS; Wang, HE; Wei, HJ; Yu, HM	1
Blasberg, R; Brader, P; Burnazi, EM; Cai, S; Fong, Y; Ghani, ER; Hricak, H; Riedl, CC; Stritzker, J; Szalay, AA; Zanzonico, P	1
Choi, YY; Hwang, HS; Jang, SJ; Kim, YH; Lee, JA; Lee, MH; Paik, SS; Yoo, DH	1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and arabinofuranosyluracil

Article	Year
Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies. Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:3 Topics: Arabinofuranosyluracil; Bone Marrow; Breast Neoplasms; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Kidney; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Pilot Projects; Positron-Emission Tomography; Time Factors; Tissue Distribution	2006

Article

Year

Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies.

Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:3

Topics: Arabinofuranosyluracil; Bone Marrow; Breast Neoplasms; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Kidney; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Pilot Projects; Positron-Emission Tomography; Time Factors; Tissue Distribution

2006

Other Studies

4 other study(ies) available for fluorodeoxyglucose f18 and arabinofuranosyluracil

Article	Year
Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:8 Topics: Animals; Arabinofuranosyluracil; Carbon Radioisotopes; Fluorodeoxyglucose F18; Gene Expression; Herpesvirus 1, Human; Iodine Radioisotopes; Nucleosides; Radiopharmaceuticals; Rats; Rats, Nude; Thymidine Kinase; Tomography, Emission-Computed	2002
Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:7 Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Cell Line, Tumor; Female; Floxuridine; Fluorodeoxyglucose F18; Ganciclovir; Genetic Therapy; Herpesvirus 1, Human; Humans; Iodine Radioisotopes; Mice; Neoplasms; Prodrugs; Thymidine Kinase; Tyrosine	2006
Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Apr-15, Volume: 14, Issue:8 Topics: Animals; Arabinofuranosyluracil; Cell Line, Tumor; Escherichia coli; Fluorodeoxyglucose F18; Herpesvirus 1, Human; Mice; Neoplasms, Experimental; Positron-Emission Tomography; Probiotics; Thymidine Kinase; Tissue Distribution	2008
18F-FDG PET/CT of drug-induced myopathy in a patient with chronic hepatitis B on long-term clevudine therapy. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:4 Topics: Adult; Arabinofuranosyluracil; Fluorodeoxyglucose F18; Hepatitis B, Chronic; Humans; Male; Muscular Diseases; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed	2011